These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37980215)

  • 1. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
    Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Impact of Histologic Subtype on Receipt of Adjuvant Chemotherapy and Overall Survival in Stage III Colon Cancer: a Retrospective Cohort Analysis.
    Powers BD; Felder SI; Imanirad I; Dessureault S; Dineen SP
    J Gastrointest Cancer; 2021 Jun; 52(2):719-727. PubMed ID: 32743731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal signet-ring cell carcinoma: benefit from adjuvant chemotherapy but a poor prognostic factor.
    Hugen N; Verhoeven RH; Lemmens VE; van Aart CJ; Elferink MA; Radema SA; Nagtegaal ID; de Wilt JH
    Int J Cancer; 2015 Jan; 136(2):333-9. PubMed ID: 24841868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superior survival in right-sided versus left-sided colon signet ring cell carcinoma.
    Zhao Z; Wang DW; Yan N; Pan S; Li ZW
    Sci Rep; 2020 Oct; 10(1):17900. PubMed ID: 33087797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of signet ring cell histology in stage I/II colon cancer-a population-based, propensity score-matched analysis.
    Ackermann CJ; Guller U; Jochum W; Schmied BM; Warschkow R
    Int J Colorectal Dis; 2018 Sep; 33(9):1183-1193. PubMed ID: 29881972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
    Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
    Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathological features and survival outcomes of primary signet ring cell and mucinous adenocarcinoma of colon: retrospective analysis of VACCR database.
    Thota R; Fang X; Subbiah S
    J Gastrointest Oncol; 2014 Feb; 5(1):18-24. PubMed ID: 24490039
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should Signet Ring Cell Histology Alter the Treatment Approach for Clinical Stage I Gastric Cancer?
    Turgeon MK; Gamboa AC; Rupji M; Lee RM; Switchenko JM; El-Rayes BF; Russell MC; Cardona K; Kooby DA; Staley CA; Maithel SK; Shah MM
    Ann Surg Oncol; 2021 Jan; 28(1):97-105. PubMed ID: 32524459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of Signet Ring Cell Carcinoma of the Colon and Rectum and their Distinction of Mucinous Adenocarcinoma with Signet Ring Cells. A Comparative Study.
    Pozos-Ochoa LI; Lino-Silva LS; León-Takahashi AM; Salcedo-Hernández RA
    Pathol Oncol Res; 2018 Jul; 24(3):609-616. PubMed ID: 28785968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological Features and Survival of Signet-Ring Cell Carcinoma and Mucinous Adenocarcinoma of Right Colon, Left Colon, and Rectum.
    Zhu L; Ling C; Xu T; Zhang J; Zhang Y; Liu Y; Fang C; Yang L; Zhuang W; Wang R; Ping J; Wang M
    Pathol Oncol Res; 2021; 27():1609800. PubMed ID: 34276258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
    Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
    Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
    Hodges N; Mackenzie H; D'Souza N; Brown G; Miskovic D
    Eur J Surg Oncol; 2022 Apr; 48(4):841-849. PubMed ID: 34688513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphovascular Invasion and Perineural Invasion Negatively Impact Overall Survival for Stage II Adenocarcinoma of the Colon.
    Skancke M; Arnott SM; Amdur RL; Siegel RS; Obias VJ; Umapathi BA
    Dis Colon Rectum; 2019 Feb; 62(2):181-188. PubMed ID: 30640833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
    Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
    Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathology and outcomes for mucinous and signet ring colorectal adenocarcinoma: analysis from the National Cancer Data Base.
    Hyngstrom JR; Hu CY; Xing Y; You YN; Feig BW; Skibber JM; Rodriguez-Bigas MA; Cormier JN; Chang GJ
    Ann Surg Oncol; 2012 Sep; 19(9):2814-21. PubMed ID: 22476818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of clinicopathological and prognostic characteristics in patients with mucinous carcinoma and signet ring cell carcinoma of the stomach.
    Bozkaya Y; Erdem GU; Ozdemir NY; Demirci NS; Hocazade C; Yazıcı O; Zengin N
    Curr Med Res Opin; 2017 Jan; 33(1):109-116. PubMed ID: 27646639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of metachronous peritoneal metastases in patients with pT4a versus pT4b colon cancer: An international multicentre cohort study.
    Bastiaenen VP; Aalbers AGJ; Arjona-Sánchez A; Bellato V; van der Bilt JDW; D'Hoore AD; Espinosa-Redondo E; Klaver CEL; Nagtegaal ID; van Ramshorst B; van Santvoort HC; Sica GS; Snaebjornsson P; Wasmann KATGM; de Wilt JHW; Wolthuis AM; Tanis PJ
    Eur J Surg Oncol; 2021 Sep; 47(9):2405-2413. PubMed ID: 34030920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical outcomes and predictors of overall survival of stage I-III appendiceal adenocarcinoma: Retrospective cohort analysis of the national cancer database.
    Emile SH; Horesh N; Freund MR; Silva-Alvarenga E; Garoufalia Z; Gefen R; Wexner SD
    Surg Oncol; 2024 Feb; 52():102034. PubMed ID: 38211448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving survival of stage II-III primary gastric signet ring cell carcinoma by adjuvant chemoradiotherapy.
    Li Y; Zhu Z; Ma F; Xue L; Tian Y
    Cancer Med; 2020 Sep; 9(18):6617-6628. PubMed ID: 32744431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Options for Signet Ring Cell Carcinoma of the Urinary Bladder: A Population-Based Study.
    Xie Y; Zhang Y; Du Z; Liu D; Yan W; Liu Y; Ping H
    Cancer Control; 2024; 31():10732748241278485. PubMed ID: 39159955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.